Skip to main content
logo
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
11.05
-1.14 (-9.35%)
At close: Jan 2, 2026, 4:00 PM EST
11.07
+0.02 (0.18%)
After-hours: Jan 2, 2026, 5:23 PM EST

Tenax Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
20.516.795.015.686.385.31
Upgrade
Research & Development
26.7312.713.235.3825.154.56
Upgrade
Operating Expenses
47.2319.498.2311.0531.539.87
Upgrade
Operating Income
-47.23-19.49-8.23-11.05-31.53-9.87
Upgrade
Interest Expense
--0.02-0.02-0-0-0
Upgrade
Interest & Investment Income
3.931.910.48---
Upgrade
Other Non Operating Income (Expenses)
-0.0200.060.010.020.03
Upgrade
EBT Excluding Unusual Items
-43.33-17.6-7.71-11.05-31.51-9.84
Upgrade
Gain (Loss) on Sale of Investments
-----0.01-0.01
Upgrade
Gain (Loss) on Sale of Assets
---0--
Upgrade
Other Unusual Items
-----0.95-
Upgrade
Pretax Income
-43.33-17.6-7.71-11.05-32.47-9.85
Upgrade
Net Income
-43.33-17.6-7.71-11.05-32.47-9.85
Upgrade
Net Income to Common
-43.33-17.6-7.71-11.05-32.47-9.85
Upgrade
Shares Outstanding (Basic)
3815000-
Upgrade
Shares Outstanding (Diluted)
3815000-
Upgrade
Shares Change (YoY)
505.18%6046.87%1250.92%43.00%--
Upgrade
EPS (Basic)
-1.14-1.15-31.04-600.72-2525.03-
Upgrade
EPS (Diluted)
-1.14-1.15-31.04-600.72-2525.03-
Upgrade
Free Cash Flow
-25.91-14.81-5.9-11.39-10.86-9.28
Upgrade
Free Cash Flow Per Share
-0.68-0.97-23.76-619.37-844.53-
Upgrade
EBITDA
--19.49-8.23-11.05-31.52-9.86
Upgrade
D&A For EBITDA
-0.010.010.0100
Upgrade
EBIT
-47.23-19.49-8.23-11.05-31.53-9.87
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q